What are the primary recommendations for managing Acute Respiratory Distress Syndrome (ARDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Respiratory Distress Syndrome (ARDS)

All patients with ARDS must receive lung-protective mechanical ventilation with tidal volumes of 4-8 mL/kg predicted body weight and plateau pressures ≤30 cmH₂O, and patients with severe ARDS (PaO₂/FiO₂ <100-150 mmHg) require prone positioning for >12 hours daily. 1

Universal ARDS Management: Apply to All Patients

Lung-Protective Ventilation (Strong Recommendation)

  • Set tidal volume at 6 mL/kg predicted body weight (acceptable range 4-8 mL/kg PBW) 1
    • Calculate predicted body weight: Males = 50 + 0.91 × [height (cm) - 152.4] kg; Females = 45.5 + 0.91 × [height (cm) - 152.4] kg 2
  • Maintain plateau pressure <30 cmH₂O at all times 1, 3
  • Accept permissive hypercapnia (pH >7.20) as a consequence of lung protection 2
  • This is the only intervention with consistent mortality benefit across all ARDS severity levels 1

Corticosteroids (Conditional Recommendation - New 2024)

  • Administer systemic corticosteroids to all mechanically ventilated ARDS patients 1
  • This represents updated guidance from the 2024 American Thoracic Society guidelines with moderate certainty of evidence 1

Fluid Management

  • Use conservative fluid strategy in established ARDS without tissue hypoperfusion 2
  • Conservative management improves ventilator-free days without increasing non-pulmonary organ failures 2

Severity-Based Management Algorithm

Mild ARDS (PaO₂/FiO₂ 201-300 mmHg)

  • Apply lung-protective ventilation as above 1
  • Use lower PEEP strategy (typically <10 cmH₂O) 2
  • Monitor for progression to moderate/severe disease 1

Moderate ARDS (PaO₂/FiO₂ 101-200 mmHg)

  • Apply lung-protective ventilation as above 1
  • Use higher PEEP (typically 10-15 cmH₂O) without recruitment maneuvers 1, 2
    • The 2024 guidelines provide conditional recommendation for higher PEEP with low-to-moderate certainty 1
  • Consider neuromuscular blockade for up to 48 hours if PaO₂/FiO₂ approaches <150 mmHg 1
  • Monitor closely for progression requiring prone positioning 1

Severe ARDS (PaO₂/FiO₂ <100-150 mmHg)

  • Apply lung-protective ventilation as above 1
  • Implement prone positioning for at least 12-16 hours daily immediately 1, 2
    • This is a strong recommendation with moderate confidence; prone positioning reduces mortality (RR 0.74) 1, 2
    • Duration matters: trials with >12 hours/day showed mortality benefit, shorter durations did not 2
  • Use higher PEEP (typically 10-15 cmH₂O) 1, 2
  • Administer neuromuscular blocking agents for up to 48 hours 1, 2
    • Use intermittent boluses rather than continuous infusion when possible 2
    • Reserve continuous infusion for persistent ventilator dyssynchrony, need for deep sedation, prone positioning, or persistently high plateau pressures 2

Refractory Severe ARDS

  • Consider VV-ECMO only at experienced centers for carefully selected patients 1, 2
    • This is a conditional recommendation with low certainty of evidence 1
    • Reserve for patients with severe refractory ARDS despite optimized ventilation, proning, and other rescue therapies 2

Strong Recommendations AGAINST Specific Interventions

High-Frequency Oscillatory Ventilation

  • Do NOT use high-frequency oscillatory ventilation routinely 1, 2
  • This is a strong recommendation against with high confidence in effect estimates 1

Prolonged Recruitment Maneuvers

  • Do NOT use prolonged lung recruitment maneuvers 1
  • The 2024 guidelines provide a strong recommendation against this practice with moderate certainty 1
  • While brief recruitment maneuvers received conditional recommendation in 2017 guidelines, the 2024 update specifically recommends against prolonged maneuvers 1

Critical Pitfalls to Avoid

  • Never prioritize normocapnia over lung-protective ventilation—accept permissive hypercapnia as necessary 2
  • Never use tidal volumes >8 mL/kg PBW even if plateau pressures are acceptable—both parameters must be optimized simultaneously 1, 2
  • Never delay prone positioning in severe ARDS—early implementation improves outcomes and this is now a strong recommendation 1, 2
  • Never apply higher PEEP indiscriminately—tailor to ARDS severity (higher for moderate-severe, lower for mild) 1, 2
  • Never use recruitment maneuvers routinely or for prolonged periods—these are associated with harm in the most recent evidence 1

Oxygenation Targets

  • Target SpO₂ of 88-95% to avoid hyperoxia while maintaining adequate oxygenation 2
  • Start supplemental oxygen if SpO₂ <92%, definitely if <90% 2
  • Maintain SpO₂ no higher than 96% in acute hypoxemic respiratory failure 2

Key Evidence Updates

The 2024 American Thoracic Society guidelines represent the most recent high-quality evidence and supersede the 2017 recommendations in several areas 1. The major updates include new conditional recommendations for corticosteroids, VV-ECMO, and neuromuscular blockade, plus a strong recommendation against prolonged recruitment maneuvers (which previously had conditional support) 1. The core lung-protective ventilation strategy and prone positioning for severe ARDS remain unchanged as strong recommendations from 2017 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Acute Respiratory Distress Syndrome (ARDS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ventilator Management for ICU Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.